BLS Pharmaceuticals Limited
Limited financial coverage for BLS.AX.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
BLS Pharmaceuticals Ltd. engages in the research, development, market and distribution of health products. It operates through the following segments: Wholesale, Plant Based, and Direct Sales.
- CEO
- Sam Watson
- IPO
- 2000
- HQ
- Sydney, NSW, AU
Get TickerSpark's AI analysis on BLS.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- 52W High
- $1.10
- 52W Low
- $0.33
- 50D MA
- $0.91
- 200D MA
- $0.63
- Beta
- 0.62
- RSI (14)
- 60
- Avg Volume
- 269.78K
No earnings-call transcripts are available for BLS.AX yet.
- Free Float
- —
- Shares Outstanding
- 229.10M
- Float Shares
- 68.49M
Our BLS.AX coverage
Recent articles, reports, and earnings notes.
No research on BLS.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BLS.AX report →